title: Tumour necrosis factor-alpha polymorphism increases risk of nonvariceal upper gastrointestinal bleeding among patients taking proton pump inhibitors.
authors.forename: Mamatha
authors.initials: M
authors.lastname: Bhat
authors.forename: Yidan
authors.initials: Y
authors.lastname: Lu
authors.forename: Valerie
authors.initials: V
authors.lastname: Marcil
authors.forename: Devendra
authors.initials: D
authors.lastname: Amre
authors.forename: Myriam
authors.initials: M
authors.lastname: Martel
authors.forename: Ernest
authors.initials: E
authors.lastname: Seidman
authors.forename: Alan
authors.initials: A
authors.lastname: Barkun
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D019317:Evidence-Based Medicine; D006471:Gastrointestinal Hemorrhage / Q000175:diagnosis / Q000235:genetics*; D005838:Genotype; D016481:Helicobacter Infections / Q000188:drug therapy; D006801:Humans; D009154:Mutation; D020641:Polymorphism, Single Nucleotide; D011237:Predictive Value of Tests; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D012680:Sensitivity and Specificity; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics*
chemical_list: D015415:Biomarkers; D054328:Proton Pump Inhibitors; D014409:Tumor Necrosis Factor-alpha